122 related articles for article (PubMed ID: 19178672)
1. Serum vascular endothelial growth factor concentrations and postsurgical outcome in dogs with osteosarcoma.
Thamm DH; O'Brien MG; Vail DM
Vet Comp Oncol; 2008 Jun; 6(2):126-32. PubMed ID: 19178672
[TBL] [Abstract][Full Text] [Related]
2. Plasma vascular endothelial growth factor (VEGF) measured in seventy dogs with spontaneously occurring tumours.
Wergin MC; Kaser-Hotz B
In Vivo; 2004; 18(1):15-9. PubMed ID: 15011746
[TBL] [Abstract][Full Text] [Related]
3. The influence of fractionated radiation therapy on plasma vascular endothelial growth factor (VEGF) concentration in dogs with spontaneous tumors and its impact on outcome.
Wergin MC; Roos M; Inteeworn N; Laluhovà D; Allemann K; Kaser-Hotz B
Radiother Oncol; 2006 May; 79(2):239-44. PubMed ID: 16677728
[TBL] [Abstract][Full Text] [Related]
4. The association between vascular endothelial growth factor levels and clinically evident peripheral edema in dogs with systemic inflammatory response syndrome.
Silverstein DC; Montealegre C; Shofer FS; Otto CM
J Vet Emerg Crit Care (San Antonio); 2009 Oct; 19(5):459-66. PubMed ID: 19821887
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of serum vascular endothelial growth factor (VEGF) and plasma activity of matrix metalloproteinase (MMP) 2 and 9 in lymphoma-affected dogs.
Gentilini F; Calzolari C; Turba ME; Agnoli C; Fava D; Forni M; Bergamini PF
Leuk Res; 2005 Nov; 29(11):1263-9. PubMed ID: 15893373
[TBL] [Abstract][Full Text] [Related]
6. Expression of vascular endothelial growth factor in tumors and plasma from dogs with primary intracranial neoplasms.
Rossmeisl JH; Duncan RB; Huckle WR; Troy GC
Am J Vet Res; 2007 Nov; 68(11):1239-45. PubMed ID: 17975980
[TBL] [Abstract][Full Text] [Related]
7. The role of circulating angiogenic factors in patients operated on for localized malignant melanoma.
Bolander A; Wagenius G; Larsson A; Brattström D; Ullenhag G; Hesselius P; Ekman S; Bergqvist M
Anticancer Res; 2007; 27(5A):3211-7. PubMed ID: 17970063
[TBL] [Abstract][Full Text] [Related]
8. Induction of VEGF by tepoxalin does not lead to increased tumour growth in a canine osteosarcoma xenograft.
Sottnik JL; Hansen RJ; Gustafson DL; Dow SW; Thamm DH
Vet Comp Oncol; 2011 Jun; 9(2):118-30. PubMed ID: 21569197
[TBL] [Abstract][Full Text] [Related]
9. TP53 gene mutations in canine osteosarcoma.
Kirpensteijn J; Kik M; Teske E; Rutteman GR
Vet Surg; 2008 Jul; 37(5):454-60. PubMed ID: 18986312
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of proangiogenic cytokines in children with lymphomas.
Mizia-Malarz A; Sobol G; Janowska J; Wos H; Zahorska-Markiewicz B
Pediatr Blood Cancer; 2009 Dec; 53(7):1195-9. PubMed ID: 19621434
[TBL] [Abstract][Full Text] [Related]
11. Aqueous humor vascular endothelial growth factor in dogs: association with intraocular disease and the development of pre-iridal fibrovascular membrane.
Sandberg CA; Herring IP; Huckle WR; LeRoith T; Pickett JP; Rossmeisl JH
Vet Ophthalmol; 2012 Mar; 15 Suppl 1():21-30. PubMed ID: 22050642
[TBL] [Abstract][Full Text] [Related]
12. Prospective evaluation of toceranib phosphate in metastatic canine osteosarcoma.
Laver T; London CA; Vail DM; Biller BJ; Coy J; Thamm DH
Vet Comp Oncol; 2018 Mar; 16(1):E23-E29. PubMed ID: 28621057
[TBL] [Abstract][Full Text] [Related]
13. High preoperative serum vascular endothelial growth factor levels predict poor clinical outcome after curative resection of gastric cancer.
Vidal O; Metges JP; Elizalde I; Valentíni M; Volant A; Molina R; Castells A; Pera M
Br J Surg; 2009 Dec; 96(12):1443-51. PubMed ID: 19918848
[TBL] [Abstract][Full Text] [Related]
14. The impact of carboplatin and toceranib phosphate on serum vascular endothelial growth factor (VEGF) and metalloproteinase-9 (MMP-9) levels and survival in canine osteosarcoma.
Gieger TL; Nettifee-Osborne J; Hallman B; Johannes C; Clarke D; Nolan MW; Williams LE
Can J Vet Res; 2017 Jul; 81(3):199-205. PubMed ID: 28725110
[TBL] [Abstract][Full Text] [Related]
15. Serum vascular endothelial growth factor in dogs with soft tissue sarcomas.
de Queiroz GF; Dagli ML; Meira SA; Matera JM
Vet Comp Oncol; 2013 Sep; 11(3):230-5. PubMed ID: 22372675
[TBL] [Abstract][Full Text] [Related]
16. Low-dose simultaneous delivery of adenovirus encoding hepatocyte growth factor and vascular endothelial growth factor in dogs enhances liver proliferation without systemic growth factor elevation.
Atta HM; Al-Hendy A; Salama SA; Shaker OG; Hammam OA
Liver Int; 2009 Aug; 29(7):1022-30. PubMed ID: 19515220
[TBL] [Abstract][Full Text] [Related]
17. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.
Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J
Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984
[TBL] [Abstract][Full Text] [Related]
18. Expression of epidermal growth factor receptor and vascular endothelial growth factor in malignant canine epithelial nasal tumours.
Shiomitsu K; Johnson CL; Malarkey DE; Pruitt AF; Thrall DE
Vet Comp Oncol; 2009 Jun; 7(2):106-14. PubMed ID: 19453364
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of plasma and serum vascular endothelial growth factor in asthma.
Lee KY; Lee KS; Park SJ; Kim SR; Min KH; Choe YH; Lee YC
J Asthma; 2008 Nov; 45(9):735-9. PubMed ID: 18972287
[TBL] [Abstract][Full Text] [Related]
20. Glucose transporter 1 expression in canine osteosarcoma.
Petty JC; Lana SE; Thamm DH; Charles JB; Bachand AM; Bush JM; Ehrhart EJ
Vet Comp Oncol; 2008 Jun; 6(2):133-40. PubMed ID: 19178673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
